[Lithium in the treatment of periodically occurring catatonic arousal states in schizophrenic patients].
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001143:Arousal / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy*; D012560:Schizophrenia, Catatonic / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000188:drug therapy
D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D008094:Lithium
Lithium in der Behandlung periodisch auftretender katatoner Erregungszustände bei Schizophrenen.